SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-019158
Filing Date
2024-07-03
Accepted
2024-07-03 16:04:04
Documents
2
Period of Report
2024-07-01

Document Format Files

Seq Description Document Type Size
1 form3-07032024_080700.html 3  
1 form3-07032024_080700.xml 3 1703
2 ex24-07032024_080705.htm EX-24 5562
  Complete submission text file 0001415889-24-019158.txt   8722
Mailing Address C/O GLOBAL BLOOD THERAPEUTICS 171 OYSTER POINT BLVD, STE. 300 SAN FRANCISCO CA 94080
Business Address
JOHNSON DAVID LEE (Reporting) CIK: 0001733883 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40407 | Film No.: 241100039

Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Issuer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)